Correlation Between X4 Pharmaceuticals and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Caribou Biosciences, you can compare the effects of market volatilities on X4 Pharmaceuticals and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Caribou Biosciences.
Diversification Opportunities for X4 Pharmaceuticals and Caribou Biosciences
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between XFOR and Caribou is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Caribou Biosciences go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Caribou Biosciences
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 1.23 times more return on investment than Caribou Biosciences. However, X4 Pharmaceuticals is 1.23 times more volatile than Caribou Biosciences. It trades about 0.0 of its potential returns per unit of risk. Caribou Biosciences is currently generating about -0.03 per unit of risk. If you would invest 129.00 in X4 Pharmaceuticals on August 25, 2024 and sell it today you would lose (95.20) from holding X4 Pharmaceuticals or give up 73.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Caribou Biosciences
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Caribou Biosciences |
X4 Pharmaceuticals and Caribou Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Caribou Biosciences
The main advantage of trading using opposite X4 Pharmaceuticals and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.| X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. HCW Biologics | X4 Pharmaceuticals vs. RenovoRx | X4 Pharmaceuticals vs. Tempest Therapeutics |
| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |